Therapeutic Application of estrogenoreceptor beta Selective agonists (eru00df) to cause somatotroph and anticatabolic Effects, organotropos

摘要

Refers to the preparation of Drugs through the use of selective agonists estrogenoreceptor (eru00df) as Sixth - Vinyl - 1,3,10 - 3,17u00df estratrien - diol, somatotroph and / or organotropos cause effects on the central nervous system, Circulatory System, bone and / or immune The Body of an elderly person (anti catabolic Therapy).Also, this medicine stimulates the growth hormone, igf-i, influencing the growth of muscle mass and bone mass, among others